What is Tedor Pharma?
Tedor Pharma operates as a sophisticated contract development and manufacturing organization (CDMO) based in the United States. With a legacy spanning over two decades, the firm provides an integrated suite of services that encompasses formulation development, analytical testing, and clinical trial supply management. By maintaining an FDA-registered and DEA-licensed facility, Tedor Pharma distinguishes itself as a high-compliance partner for pharmaceutical innovators. The company specializes in the production of solid dose pharmaceuticals and controlled substances, offering end-to-end outsourcing solutions that cater to the rigorous demands of small molecule drug development. Their market position is defined by a blend of technical expertise and regulatory excellence, enabling them to support clients from early-stage development through to full-scale commercial manufacturing.
How much funding has Tedor Pharma raised?
Tedor Pharma has raised a total of $1.9M across 2 funding rounds:
Debt
$1M
Debt
$949K
Debt (2020): $1M with participation from PPP
Debt (2021): $949K led by PPP
Key Investors in Tedor Pharma
PPP
Public-Private Partnership
What's next for Tedor Pharma?
With the recent influx of capital, Tedor Pharma is well-positioned to accelerate its strategic growth initiatives. The company is expected to leverage this financing to enhance its manufacturing capacity and further optimize its process development workflows. As the pharmaceutical industry continues to prioritize reliable, domestic outsourcing partners, Tedor Pharma's focus on high-quality solid dose production will likely serve as a primary driver for future expansion. The firm is poised to deepen its service offerings, potentially integrating advanced analytical capabilities to meet the evolving needs of its client base. By maintaining its focus on regulatory compliance and operational efficiency, Tedor Pharma is set to strengthen its competitive advantage in the global CDMO landscape, ensuring long-term sustainability and continued value creation for its stakeholders.
See full Tedor Pharma company page
